A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women with breast cancer. Participants will be randomized to abemaciclib or placebo in a 2:1 ratio.
Epistemonikos ID: 25ed548bfe75eeb281d315ccb20b4bc33a212b1a
First added on: Oct 05, 2017